Centre Hospitalier Universitaire De Saint Etienne

Research site

France CHU de Saint Etienne Institut de cancérologie et d’hématologie universitaire de Saint Etienne, 42055 Saint-Etienne, France

Adult patients

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

CHU de Saint Etienne Institut de cancérologie et d’hématologie universitaire de Saint Etienne42055 Saint-EtienneFrance

Open in maps ↗

Recruiting now: no trials

More sites in Saint-Etienne France

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:AstraZeneca AB

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites